Michael E. Nesheim

11.9k total citations · 3 hit papers
154 papers, 9.7k citations indexed

About

Michael E. Nesheim is a scholar working on Hematology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael E. Nesheim has authored 154 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Hematology, 41 papers in Cancer Research and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael E. Nesheim's work include Blood Coagulation and Thrombosis Mechanisms (116 papers), Protease and Inhibitor Mechanisms (41 papers) and Hemophilia Treatment and Research (38 papers). Michael E. Nesheim is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (116 papers), Protease and Inhibitor Mechanisms (41 papers) and Hemophilia Treatment and Research (38 papers). Michael E. Nesheim collaborates with scholars based in Canada, United States and Netherlands. Michael E. Nesheim's co-authors include Kenneth G. Mann, Laszlo Bajzar, John Morser, Michael B. Boffa, Paula B. Tracy, Alan R. Giles, John B. Walker, Lyndon S. Hibbard, Marlys L. Koschinsky and Sriram Krishnaswamy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Michael E. Nesheim

154 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis Inhibitor

1995 534 citations Laszlo Bajzar, Michael E. Nesheim et al. Journal of Biological Chemistry profile →
TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex

1996 506 citations Laszlo Bajzar, John Morser et al. Journal of Biological Chemistry profile →
The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.

1979 501 citations Michael E. Nesheim et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael E. Nesheim Canada	52	7.2k	1.8k	1.7k	1.7k	1.6k	154	9.7k
Walter Kisiel United States	57	6.6k 0.9×	3.1k 1.7×	1.7k 1.0×	2.3k 1.4×	1.3k 0.8×	165	11.1k
Yale Nemerson United States	58	7.9k 1.1×	2.2k 1.2×	1.1k 0.6×	2.2k 1.3×	2.1k 1.3×	145	12.7k
Whyte G. Owen United States	42	3.6k 0.5×	1.8k 1.0×	1.0k 0.6×	769 0.5×	812 0.5×	128	6.6k
Jan A. van Mourik Netherlands	55	5.7k 0.8×	1.9k 1.0×	1.3k 0.7×	1.6k 1.0×	978 0.6×	172	9.2k
Jan J. Sixma Netherlands	43	4.1k 0.6×	2.0k 1.1×	802 0.5×	799 0.5×	1.2k 0.7×	155	7.7k
Inga Marie Nilsson Sweden	49	5.5k 0.8×	730 0.4×	666 0.4×	1.3k 0.8×	1.4k 0.8×	254	8.6k
CT Esmon United States	32	4.4k 0.6×	726 0.4×	454 0.3×	1.1k 0.6×	538 0.3×	51	6.2k
Dan Eaton United States	43	5.3k 0.7×	2.5k 1.4×	1.8k 1.0×	1.8k 1.0×	1.2k 0.7×	76	11.7k
D.C. Rijken Netherlands	45	3.3k 0.5×	1.4k 0.8×	3.4k 2.0×	451 0.3×	2.2k 1.3×	134	7.3k
Martine Jandrot‐Perrus France	46	3.3k 0.5×	1.2k 0.7×	632 0.4×	592 0.4×	1.2k 0.7×	174	6.1k

Countries citing papers authored by Michael E. Nesheim

Since Specialization

Citations

This map shows the geographic impact of Michael E. Nesheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Nesheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Nesheim more than expected).

Fields of papers citing papers by Michael E. Nesheim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Nesheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Nesheim. The network helps show where Michael E. Nesheim may publish in the future.

Co-authorship network of co-authors of Michael E. Nesheim

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Nesheim. A scholar is included among the top collaborators of Michael E. Nesheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Nesheim. Michael E. Nesheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Foley, Jonathan H., Paul Cook, & Michael E. Nesheim. (2011). Kinetics of Activated Thrombin-activatable Fibrinolysis Inhibitor (TAFIa)-catalyzed Cleavage of C-terminal Lysine Residues of Fibrin Degradation Products and Removal of Plasminogen-binding Sites. Journal of Biological Chemistry. 286(22). 19280–19286. 15 indexed citations

Kim, Paul Y. & Michael E. Nesheim. (2010). Down regulation of prothrombinase by activated protein C during prothrombin activation. Thrombosis and Haemostasis. 104(7). 61–70. 10 indexed citations

Kim, Paul Y., et al.. (2009). Differences in prethrombin-1 activation with human or bovine factor Va can be attributed to the heavy chain. Thrombosis and Haemostasis. 102(10). 623–633. 3 indexed citations

Foley, Jonathan H. & Michael E. Nesheim. (2008). Soluble thrombomodulin partially corrects the premature lysis defect in FVIII‐deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor. Journal of Thrombosis and Haemostasis. 7(3). 453–459. 19 indexed citations

Wu, Chengliang, Paul Y. Kim, Marian Seto, et al.. (2008). The Roles of Selected Arginine and Lysine Residues of TAFI (Pro-CPU) in Its Activation to TAFIa by the Thrombin-Thrombomodulin Complex. Journal of Biological Chemistry. 284(11). 7059–7067. 25 indexed citations

Foley, Jonathan H., et al.. (2007). An assay for measuring functional activated thrombin-activatable fibrinolysis inhibitor in plasma. Analytical Biochemistry. 372(1). 32–40. 22 indexed citations

Bukys, Michael A., Paul Y. Kim, Michael E. Nesheim, & Michael Kalafatis. (2006). A Control Switch for Prothrombinase. Journal of Biological Chemistry. 281(51). 39194–39204. 23 indexed citations

Senis, Yotis A., Paul Y. Kim, Ángel Galindo García, et al.. (2006). Isolation and characterization of cotiaractivase, a novel low molecular weight prothrombin activator from the venom of Bothrops cotiara. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1764(5). 863–871. 16 indexed citations

Bukys, Michael A., et al.. (2005). Incorporation of Factor Va into Prothrombinase Is Required for Coordinated Cleavage of Prothrombin by Factor Xa. Journal of Biological Chemistry. 280(29). 27393–27401. 30 indexed citations

10.

Maret, Deborah, et al.. (2004). Role of mRNA transcript stability in modulation of expression of the gene encoding thrombin activable fibrinolysis inhibitor. Journal of Thrombosis and Haemostasis. 2(11). 1969–1979. 30 indexed citations

11.

Hancock, Mark A., Michael B. Boffa, Santica M. Marcovina, Michael E. Nesheim, & Marlys L. Koschinsky. (2003). Inhibition of Plasminogen Activation by Lipoprotein(a). Journal of Biological Chemistry. 278(26). 23260–23269. 108 indexed citations

12.

Nesheim, Michael E.. (2003). Thrombin and Fibrinolysis. CHEST Journal. 124(3). 33S–39S. 101 indexed citations

13.

Boskovic, Danilo S., Laszlo Bajzar, & Michael E. Nesheim. (2001). Channeling During Prothrombin Activation. Journal of Biological Chemistry. 276(31). 28686–28693. 26 indexed citations

14.

Wang, Wei, Mariko Nagashima, Mark Schneider, John Morser, & Michael E. Nesheim. (2000). Elements of the Primary Structure of Thrombomodulin Required for Efficient Thrombin-activable Fibrinolysis Inhibitor Activation. Journal of Biological Chemistry. 275(30). 22942–22947. 81 indexed citations

15.

Boffa, Michael B., et al.. (2000). Roles of Thermal Instability and Proteolytic Cleavage in Regulation of Activated Thrombin-activable Fibrinolysis Inhibitor. Journal of Biological Chemistry. 275(17). 12868–12878. 93 indexed citations

16.

Bajzar, Laszlo, Michael E. Nesheim, John Morser, & Paula B. Tracy. (1998). Both Cellular and Soluble Forms of Thrombomodulin Inhibit Fibrinolysis by Potentiating the Activation of Thrombin-activable Fibrinolysis Inhibitor. Journal of Biological Chemistry. 273(5). 2792–2798. 88 indexed citations

17.

Wang, Wei, Michael B. Boffa, Laszlo Bajzar, John B. Walker, & Michael E. Nesheim. (1998). A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor. Journal of Biological Chemistry. 273(42). 27176–27181. 309 indexed citations

18.

Pannekoek, Hans, et al.. (1997). A Steady-state Template Model That Describes the Kinetics of Fibrin-stimulated [Glu1]- and [Lys78]Plasminogen Activation by Native tissue-type Plasminogen Activator and Variants That Lack Either the Finger or Kringle-2 Domain. Journal of Biological Chemistry. 272(4). 2183–2191. 51 indexed citations

19.

Borne, Peter A. von dem, Laszlo Bajzar, Joost C.M. Meijers, Michael E. Nesheim, & Bonno N. Bouma. (1997). Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.. Journal of Clinical Investigation. 99(10). 2323–2327. 189 indexed citations

20.

Tracy, Paula B., Michael E. Nesheim, & K G Mann. (1992). Platelet factor Xa receptor. Methods in enzymology on CD-ROM/Methods in enzymology. 215. 329–360. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact